General Ophthalmology - Eye Health Academy

33-48 of 74

Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Eye on Ocular Health
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Examining Therapeutic Timing in RVO-Related Macular Edema
Eye on Ocular Health
Examining Therapeutic Timing in RVO-Related Macular Edema
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Eye on Ocular Health
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
- Ryan Quigley
Practice Efficiency and Innovation
Practice Efficiency and Innovation
Modern Optometry
Practice Efficiency and Innovation
Jacob Lang
- Jacob Lang
Elevating Clinical Efficiency
Elevating Clinical Efficiency
Modern Optometry
Elevating Clinical Efficiency
Diana Chu
- Diana Chu
Redefining The Cash-Pay Model in Modern Optometric Practice
Redefining The Cash-Pay Model in Modern Optometric Practice
Modern Optometry
Redefining The Cash-Pay Model in Modern Optometric Practice
Jason E. Compton, OD, FAAO
- Jason E. Compton, OD, FAAO
Strategies for Addressing Complications in Retinal Vein Occlusion
Strategies for Addressing Complications in Retinal Vein Occlusion
Eye on Ocular Health
Strategies for Addressing Complications in Retinal Vein Occlusion
Lisa Schocket, MD
- Lisa Schocket, MD
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Eye on Ocular Health
The Evolution of Retinal Vein Occlusion Treatment: From Laser to Anti-VEGF
Lisa Schocket, MD
- Lisa Schocket, MD
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular Health
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Houman Hemmati, MD, PhD
- Houman Hemmati, MD, PhD
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular Health
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Houman Hemmati, MD, PhD
- Houman Hemmati, MD, PhD
Personalizing Treatment for Chronic Ocular Surface Pain
Personalizing Treatment for Chronic Ocular Surface Pain
AAO Action Center
Personalizing Treatment for Chronic Ocular Surface Pain
Anat Galor, MD, MSPH
- Anat Galor, MD, MSPH
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
AAO Action Center
Defining Chronic Ocular Surface Pain: Causes, Clues, and Complexity
Anat Galor, MD, MSPH
- Anat Galor, MD, MSPH
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
AAO Action Center
Imaging and Proteomics: Differentiating Neuropathic Corneal Pain from Dry Eye
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
AAO Action Center
Targeting Inflammation in Dry Eye with ILYX-002: Early Clinical Trial Results
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular Health
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Marlene Mimi Maeusli, PhD.
- Marlene Mimi Maeusli, PhD.
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular Health
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
- Marlene Mimi Maeusli, PhD.

3/5